Need help finding what you are looking for?
Contact Us
PUBLISHER: IMARC | PRODUCT CODE: 1390755
PUBLISHER: IMARC | PRODUCT CODE: 1390755
Gastroparesis Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
PUBLISHED:
PAGES: 149 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Abstract
The global gastroparesis drugs market size reached US$ 6.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 8.2 Billion by 2028, exhibiting a growth rate (CAGR) of 4.77% during 2022-2028.
Gastroparesis, also known as stomach paralysis, is a medical condition that affects the normal and spontaneous movement of the muscles in the stomach. It interferes with the digestion process and causes nausea, vomiting, abdominal pain, and problems with maintaining blood sugar levels and nutrition absorption. At present, it is treated under the guidance of doctors using drugs, such as domperidone, metoclopramide, erythromycin, diphenhydramine, ondansetron, and prochlorperazine.
Gastroparesis Drugs Market Trends:
Due to rapid urbanization, sedentary lifestyles and the growing number of individuals who drink and smoke regularly, there is a significant rise in the prevalence of diabetes across the globe. This, in confluence with the increasing geriatric population, which is relatively more susceptible to developing gastroparesis, represents one of the key factors bolstering the growth of the market. In addition, gastroparesis drugs aid in enhancing gastrointestinal motility by improving the frequency of contraction. As a result, they are extensively being utilized for treating idiopathic gastroparesis, which causes severe vomiting, nausea, and upper abdominal pain. This, along with a considerable rise in the number of individuals developing gastroparesis after the vague nerve and its branches are damaged via surgical operations, are also contributing to market growth. Furthermore, leading manufacturers are continuously funding research and development (R&D) projects to introduce new approaches to the existing drug therapy. They are also developing advanced and effective drugs that can be administered via the nasal cavity for individuals who are experiencing symptoms of gastroparesis, which is creating a favorable market outlook. Other major factors, including the improving healthcare infrastructure and the escalating demand for user-friendly drugs, are anticipated to impel the growth of the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global gastroparesis drugs market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on disease type, drug class and distribution channel.
Breakup by Disease Type:
Diabetic Gastroparesis
Idiopathic Gastroparesis
Post-surgical Gastroparesis
Others
Breakup by Drug Class:
Prokinetic Agents
Antiemetic Agents
Botulinum Toxin Injections
Breakup by Distribution Channel:
Hospitals and Clinics
Pharmacies
Online Stores
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Abbvie Inc., AstraZeneca Plc, Bausch Health Companies Inc., Becton Dickinson and Company, Boston Scientific Corporation, Evoke Pharma, Medtronic plc, Neurogastrx Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited and Theravance Biopharma.
Key Questions Answered in This Report
- 1. What was the size of the global gastroparesis drugs market in 2022?
- 2. What is the expected growth rate of the global gastroparesis drugs market during 2023-2028?
- 3. What has been the impact of COVID-19 on the global gastroparesis drugs market?
- 4. What are the key factors driving the global gastroparesis drugs market?
- 5. What is the breakup of the global gastroparesis drugs market based on the disease type?
- 6. What is the breakup of the global gastroparesis drugs market based on the drug class?
- 7. What is the breakup of the global gastroparesis drugs market based on the distribution channel?
- 8. What are the key regions in the global gastroparesis drugs market?
- 9. Who are the key players/companies in the global gastroparesis drugs market?
Product Code: SR112023A4608
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Gastroparesis Drugs Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Disease Type
- 6.1 Diabetic Gastroparesis
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Idiopathic Gastroparesis
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Post-surgical Gastroparesis
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Others
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
7 Market Breakup by Drug Class
- 7.1 Prokinetic Agents
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Antiemetic Agents
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Botulinum Toxin Injections
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
8 Market Breakup by Distribution Channel
- 8.1 Hospitals and Clinics
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Pharmacies
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Online Stores
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.1.1 United States
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.2.1 China
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.3.1 Germany
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.4.1 Brazil
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Abbott Laboratories
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.1.3 Financials
- 14.3.1.4 SWOT Analysis
- 14.3.2 Abbvie Inc.
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.2.3 Financials
- 14.3.2.4 SWOT Analysis
- 14.3.3 AstraZeneca Plc
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.3.3 Financials
- 14.3.3.4 SWOT Analysis
- 14.3.4 Bausch Health Companies Inc.
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.4.3 Financials
- 14.3.4.4 SWOT Analysis
- 14.3.5 Becton Dickinson and Company
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.5.3 Financials
- 14.3.5.4 SWOT Analysis
- 14.3.6 Boston Scientific Corporation
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.6.3 Financials
- 14.3.6.4 SWOT Analysis
- 14.3.7 Evoke Pharma
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.7.3 Financials
- 14.3.8 Medtronic plc
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.8.3 Financials
- 14.3.8.4 SWOT Analysis
- 14.3.9 Neurogastrx Inc.
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.10 Sanofi S.A.
- 14.3.10.1 Company Overview
- 14.3.10.2 Product Portfolio
- 14.3.11 Takeda Pharmaceutical Company Limited
- 14.3.11.1 Company Overview
- 14.3.11.2 Product Portfolio
- 14.3.11.3 Financials
- 14.3.11.4 SWOT Analysis
- 14.3.12 Theravance Biopharma
- 14.3.12.1 Company Overview
- 14.3.12.2 Product Portfolio
- 14.3.12.3 Financials
- 14.3.12.4 SWOT Analysis
- 14.3.1 Abbott Laboratories
Product Code: SR112023A4608
List of Figures
- Figure 1: Global: Gastroparesis Drugs Market: Major Drivers and Challenges
- Figure 2: Global: Gastroparesis Drugs Market: Sales Value (in Billion US$), 2017-2022
- Figure 3: Global: Gastroparesis Drugs Market Forecast: Sales Value (in Billion US$), 2023-2028
- Figure 4: Global: Gastroparesis Drugs Market: Breakup by Disease Type (in %), 2022
- Figure 5: Global: Gastroparesis Drugs Market: Breakup by Drug Class (in %), 2022
- Figure 6: Global: Gastroparesis Drugs Market: Breakup by Distribution Channel (in %), 2022
- Figure 7: Global: Gastroparesis Drugs Market: Breakup by Region (in %), 2022
- Figure 8: Global: Gastroparesis Drugs (Diabetic Gastroparesis) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 9: Global: Gastroparesis Drugs (Diabetic Gastroparesis) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 10: Global: Gastroparesis Drugs (Idiopathic Gastroparesis) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 11: Global: Gastroparesis Drugs (Idiopathic Gastroparesis) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 12: Global: Gastroparesis Drugs (Post-surgical Gastroparesis) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 13: Global: Gastroparesis Drugs (Post-surgical Gastroparesis) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 14: Global: Gastroparesis Drugs (Other Disease Types) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 15: Global: Gastroparesis Drugs (Other Disease Types) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 16: Global: Gastroparesis Drugs (Prokinetic Agents) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 17: Global: Gastroparesis Drugs (Prokinetic Agents) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 18: Global: Gastroparesis Drugs (Antiemetic Agents) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 19: Global: Gastroparesis Drugs (Antiemetic Agents) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 20: Global: Gastroparesis Drugs (Botulinum Toxin Injections) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 21: Global: Gastroparesis Drugs (Botulinum Toxin Injections) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 22: Global: Gastroparesis Drugs (Hospitals and Clinics) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 23: Global: Gastroparesis Drugs (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 24: Global: Gastroparesis Drugs (Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 25: Global: Gastroparesis Drugs (Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 26: Global: Gastroparesis Drugs (Online Stores) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 27: Global: Gastroparesis Drugs (Online Stores) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 28: North America: Gastroparesis Drugs Market: Sales Value (in Million US$), 2017 & 2022
- Figure 29: North America: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 30: United States: Gastroparesis Drugs Market: Sales Value (in Million US$), 2017 & 2022
- Figure 31: United States: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 32: Canada: Gastroparesis Drugs Market: Sales Value (in Million US$), 2017 & 2022
- Figure 33: Canada: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 34: Asia-Pacific: Gastroparesis Drugs Market: Sales Value (in Million US$), 2017 & 2022
- Figure 35: Asia-Pacific: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 36: China: Gastroparesis Drugs Market: Sales Value (in Million US$), 2017 & 2022
- Figure 37: China: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 38: Japan: Gastroparesis Drugs Market: Sales Value (in Million US$), 2017 & 2022
- Figure 39: Japan: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 40: India: Gastroparesis Drugs Market: Sales Value (in Million US$), 2017 & 2022
- Figure 41: India: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 42: South Korea: Gastroparesis Drugs Market: Sales Value (in Million US$), 2017 & 2022
- Figure 43: South Korea: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 44: Australia: Gastroparesis Drugs Market: Sales Value (in Million US$), 2017 & 2022
- Figure 45: Australia: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 46: Indonesia: Gastroparesis Drugs Market: Sales Value (in Million US$), 2017 & 2022
- Figure 47: Indonesia: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 48: Others: Gastroparesis Drugs Market: Sales Value (in Million US$), 2017 & 2022
- Figure 49: Others: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 50: Europe: Gastroparesis Drugs Market: Sales Value (in Million US$), 2017 & 2022
- Figure 51: Europe: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 52: Germany: Gastroparesis Drugs Market: Sales Value (in Million US$), 2017 & 2022
- Figure 53: Germany: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 54: France: Gastroparesis Drugs Market: Sales Value (in Million US$), 2017 & 2022
- Figure 55: France: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 56: United Kingdom: Gastroparesis Drugs Market: Sales Value (in Million US$), 2017 & 2022
- Figure 57: United Kingdom: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 58: Italy: Gastroparesis Drugs Market: Sales Value (in Million US$), 2017 & 2022
- Figure 59: Italy: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 60: Spain: Gastroparesis Drugs Market: Sales Value (in Million US$), 2017 & 2022
- Figure 61: Spain: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 62: Russia: Gastroparesis Drugs Market: Sales Value (in Million US$), 2017 & 2022
- Figure 63: Russia: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 64: Others: Gastroparesis Drugs Market: Sales Value (in Million US$), 2017 & 2022
- Figure 65: Others: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 66: Latin America: Gastroparesis Drugs Market: Sales Value (in Million US$), 2017 & 2022
- Figure 67: Latin America: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 68: Brazil: Gastroparesis Drugs Market: Sales Value (in Million US$), 2017 & 2022
- Figure 69: Brazil: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 70: Mexico: Gastroparesis Drugs Market: Sales Value (in Million US$), 2017 & 2022
- Figure 71: Mexico: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 72: Others: Gastroparesis Drugs Market: Sales Value (in Million US$), 2017 & 2022
- Figure 73: Others: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 74: Middle East and Africa: Gastroparesis Drugs Market: Sales Value (in Million US$), 2017 & 2022
- Figure 75: Middle East and Africa: Gastroparesis Drugs Market: Breakup by Country (in %), 2022
- Figure 76: Middle East and Africa: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 77: Global: Gastroparesis Drugs Industry: SWOT Analysis
- Figure 78: Global: Gastroparesis Drugs Industry: Value Chain Analysis
- Figure 79: Global: Gastroparesis Drugs Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Gastroparesis Drugs Market: Key Industry Highlights, 2022 and 2028
- Table 2: Global: Gastroparesis Drugs Market Forecast: Breakup by Disease Type (in Million US$), 2023-2028
- Table 3: Global: Gastroparesis Drugs Market Forecast: Breakup by Drug Class (in Million US$), 2023-2028
- Table 4: Global: Gastroparesis Drugs Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
- Table 5: Global: Gastroparesis Drugs Market Forecast: Breakup by Region (in Million US$), 2023-2028
- Table 6: Global: Gastroparesis Drugs Market: Competitive Structure
- Table 7: Global: Gastroparesis Drugs Market: Key Players
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.